| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $25.5M | — | +17.8% |
| Cost of Revenue | $310K | — | +14.8% |
| Gross Profit | $8.8M | — | +31.5% |
| R&D Expense | $778K | — | +855.4% |
| SG&A Expense | $1.8M | — | +28.0% |
| Operating Income | $5.7M | — | +18.9% |
| Pre-tax Income | $6.8M | — | +24.1% |
| Income Tax | $1.0M | — | +14.3% |
| Net Income | $5.0M | — | +24.9% |
| EPS (Basic) | $0.23 | — | -20.7% |
| EPS (Diluted) | $0.23 | — | -20.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.4M | +33.7% | +92.3% |
| Short-term Investments | $20.8M | -14.8% | +41.1% |
| Accounts Receivable | $25.9M | +50.0% | +20.8% |
| Inventory | $25.7M | +5.4% | +7.3% |
| Current Assets | $113.0M | +18.6% | +20.9% |
| Total Assets | $136.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.2M | — | -195.3% |
| Capital Expenditures | $173K | — | +1100.5% |
| Investing Cash Flow | -$4.2M | — | -494.5% |
| Financing Cash Flow | $8.1M | — | +560.8% |
| Free Cash Flow | -$1.4M | — | -210.5% |
| +15.1% |
| Current Liabilities | $56.9M | +17.9% | +1.3% |
| Total Liabilities | $58.1M | +17.5% | -4.1% |
| Stockholders' Equity | $84.3M | +15.5% | +30.4% |